(Total Views: 671)
Posted On: 06/04/2024 8:05:14 AM
Post# of 148878
Melanoma and Breast Cancer under control/combo trial?
Melanoma was uncurable 15 years ago. Progress all around us.
"The 2.5-year recurrence-free survival rate for the jab in combination with Keytruda was 74.8%, compared with 55.6% for Keytruda alone, delegates at the American Society of Clinical Oncology (ASCO) annual meeting in Chicago heard."
The study involved 400 patients with early stage breast cancer. Half were given a vaccine to stimulate their immune system before surgery.
After seven years, 81% of patients who had the vaccine were still alive and free of breast cancer, compared with 65% of those who had received standard care.
https://www.theguardian.com/society/article/2...te-doctors
Melanoma was uncurable 15 years ago. Progress all around us.
"The 2.5-year recurrence-free survival rate for the jab in combination with Keytruda was 74.8%, compared with 55.6% for Keytruda alone, delegates at the American Society of Clinical Oncology (ASCO) annual meeting in Chicago heard."
The study involved 400 patients with early stage breast cancer. Half were given a vaccine to stimulate their immune system before surgery.
After seven years, 81% of patients who had the vaccine were still alive and free of breast cancer, compared with 65% of those who had received standard care.
https://www.theguardian.com/society/article/2...te-doctors
(5)
(0)Scroll down for more posts ▼
